News

Investor News from Reuters

May 22, 2018 - REUTERS

Delcath Sponsors Looking For A Cure Ocular Melanoma Charity Event

May 16, 2018 - REUTERS

Delcath’s CHEMOSAT Included in German Treatment Guidelines for Melanoma Liver Metastases

May 14, 2018 - REUTERS

Delcath’s PHP Therapy Featured in Video Learning Session at the European Conference of Interventional Oncology 

May 10, 2018 - REUTERS

Delcath Announces First Quarter 2018 Financial Results

May 07, 2018 - REUTERS

Delcath Announces Initiation of Registrational Trial of Melphalan/HDS in Intrahepatic Cholangiocarcinoma

May 04, 2018 - REUTERS

Delcath to Present at the RHK Capital 2018 Disruptive Growth and Healthcare Conference

May 03, 2018 - REUTERS

Delcath Announces Another DSMB Recommendation for Phase 3 Focus Trial

May 01, 2018 - REUTERS

Delcath Announces Ratio for Reverse Split Authorization

April 09, 2018 - REUTERS

Delcath Announces Shareholder Approval of Consent Solicitation

April 03, 2018 - REUTERS

Delcath’s PHP Therapy to be Featured in Video Training Session at European Conference of Interventional Oncology  

March 29, 2018 - REUTERS

Summary of Recent Published Research on Delcath’s PHP Therapy Presented at Society of Surgical Oncology Annual Symposia

March 19, 2018 - REUTERS

Delcath to Present at Oppenheimer 28th Annual Healthcare Conference

March 16, 2018 - REUTERS

Delcath Announces 2017 Financial Results

March 12, 2018 - REUTERS

Delcath to Present at 30th Annual Roth Conference

March 07, 2018 - REUTERS

Delcath Announces Commercial Supply Agreement for Melphalan Hydrochloride for Injection with Tillomed Laboratories

February 02, 2018 - REUTERS

Delcath Announces 500th Commercial CHEMOSAT Treatment in Europe

February 01, 2018 - REUTERS

Delcath Announces Satisfaction of 2016 Convertible Note

January 10, 2018 - REUTERS

Delcath Announces Special Protocol Agreement Modification With FDA

January 09, 2018 - REUTERS

Positive Results From a Multi-Center Analysis of Delcath PHP Therapy Published in Journal of Surgical Oncology